The expression of CD24 in triple-negative breast cancer could help the cancer cells achieve the immune evasion through CD24-Siglec-10 signaling to inhibit the function of Tumor-associated macrophages (TAMs) (6) (Figure 1). This evidence concerns the gene CD24 and triple-negative breast carcinoma.